Eocene Ltd. Ordinary Shares (EOCN) Stock Price

EOCNStock

$3.61−69.18%52W

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta1.12

EOCN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-42.79%

Price vs S&P 500 (4W)-16.78%

VGM Score64.02

Book Value / Share (Quarterly)$16.91

P/TBV (Annual)0.09x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-9.31

Price vs S&P 500 (YTD)-53.00%

Net Profit Margin (TTM)-424.24%

EPS (TTM)$-12.13

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-12.13

EPS (Annual)$-8.09

ROI (Annual)-46.06%

Net Profit Margin (5Y Avg)-5369.04%

Cash / Share (Quarterly)$11.36

ROA (Last FY)-40.65%

EBITD / Share (TTM)$-7.57

ROE (5Y Avg)-80.13%

Operating Margin (TTM)-439.83%

Cash Flow / Share (Annual)$-7.68

P/B Ratio0.27x

P/B Ratio (Quarterly)0.23x

Net Income / Employee (Annual)$-2,506,700

EV / Revenue (TTM)0.91x

Net Interest Coverage (TTM)-93.05x

ROA (TTM)-56.15%

EPS Incl Extra (Annual)$-8.09

Current Ratio (Annual)6.55x

Quick Ratio (Quarterly)7.71x

3-Month Avg Trading Volume0.08M

52-Week Price Return-69.18%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$6.28

P/S Ratio (Annual)1.81x

Asset Turnover (Annual)0.02x

52-Week High$13.20

Operating Margin (5Y Avg)-5585.52%

EPS Excl Extra (Annual)$-8.09

Tangible BV CAGR (5Y)-3.20%

26-Week Price Return-25.87%

Quick Ratio (Annual)6.45x

13-Week Price Return-19.62%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.71x

Enterprise Value$2.10M

Asset Turnover (TTM)0.04x

Book Value / Share Growth (5Y)-9.21%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-479.41%

Cash / Share (Annual)$13.38

3-Month Return Std Dev88.90%

Net Income / Employee (TTM)$-3,705,000

ROE (Last FY)-46.06%

Net Interest Coverage (Annual)-6.64x

EPS Basic Excl Extra (Annual)$-8.09

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-12.13

ROI (TTM)-64.10%

P/S Ratio (TTM)1.60x

Pretax Margin (5Y Avg)-5365.36%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$7.99

Price vs S&P 500 (52W)-85.15%

Year-to-Date Return-39.58%

5-Day Price Return6.30%

EPS Normalized (Annual)$-8.09

ROA (5Y Avg)-66.75%

Net Profit Margin (Annual)-483.33%

Month-to-Date Return-12.01%

Cash Flow / Share (TTM)$-6.77

EBITD / Share (Annual)$-7.89

Operating Margin (Annual)-525.49%

ROI (5Y Avg)-80.13%

EPS Basic Excl Extra (TTM)$-12.13

P/TBV (Quarterly)0.12x

P/B Ratio (Annual)0.26x

Pretax Margin (TTM)-420.78%

Book Value / Share (Annual)$19.18

Price vs S&P 500 (13W)-23.52%

Beta1.12x

Revenue / Share (TTM)$0.00

ROE (TTM)-64.10%

52-Week Low$3.27

vGradeA

mGradeC

vgmGradeB

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
EOCNEocene Ltd. Ordinary Shares	A	—	C	1.6x	—	—	—	$3.61
LLYEli Lilly & Co.	D	B	B	13.5x	49.6%	83.4%	27.6%	$1142.85
JNJJohnson & Johnson	D	C	B	6.3x	8.1%	68.0%	14.9%	$256.03
ABBVABBVIE INC.	D	C	B	7.2x	10.4%	72.8%	-2.9%	$262.82
MRKMerck & Co., Inc.	D	C	B	5.3x	4.6%	77.3%	21.2%	$144.30
NVSNovartis AG	C	C	C	4.6x	3.3%	75.0%	15.3%	$141.00
AZNAstraZeneca PLC	C	B	C	4.0x	8.6%	81.3%	21.9%	$156.90
ABTAbbott Laboratories	C	C	C	3.6x	8.1%	56.8%	8.2%	$97.50
NVONovo-Nordisk A/S	B	C	C	3.4x	5.6%	80.7%	20.7%	$37.32
PFEPfizer Inc.	C	D	B	2.5x	-0.2%	74.7%	-3.5%	$27.80
VRTXVertex Pharmaceuticals Inc	D	C	B	10.4x	10.2%	86.0%	8.3%	$504.73
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$61.15
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	C	1.8x	13.4%	72.8%	-8.2%	$39.92
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	2.2x	5.0%	73.6%	-0.5%	$47.03
REGNRegeneron Pharmaceuticals Inc	C	C	B	4.9x	9.3%	86.0%	6.3%	$735.20
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	2.0x	3.1%	65.5%	-12.6%	$17.86
TEVATeva Pharmaceutical Industries Limited	D	C	B	2.7x	4.1%	52.9%	—	$39.53
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.6x	31.1%	88.5%	—	$358.07
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	13.0x	10.0%	—	-12.1%	$57.16
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	6.1x	95.1%	79.7%	—	$219.72
ZTSZOETIS INC.	C	C	C	3.1x	1.4%	71.6%	12.0%	$69.69
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3425.6x	-67.6%	81.2%	—	$35.72
INSMInsmed, Inc.	F	A	C	21.3x	185.8%	83.5%	—	$111.12
UTHRUnited Therapeutics Corp	C	C	B	7.4x	2.5%	86.1%	19.3%	$541.70
GMABGenmab A/S ADS	C	C	B	5.0x	22.3%	93.0%	6.8%	$34.75
VTRSViatris Inc. Common Stock	B	C	B	1.4x	4.4%	40.3%	—	$17.60
JAZZJazz Pharmaceuticals, Inc.	C	C	B	3.3x	12.6%	88.4%	-1.4%	$235.67
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	12.1x	113.3%	91.3%	—	$227.87
SMMTSummit Therapeutics Inc. Common Stock	F	—	B	13923.2x	—	—	—	$16.75
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.4x	202.4%	94.4%	—	$67.25
CORTCorcept Therapeutics Inc.	F	C	A	15.1x	16.0%	98.3%	-0.5%	$116.23
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	9.0x	149.0%	91.5%	—	$499.40
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.2x	11.2%	79.6%	-17.0%	$57.18
ELANElanco Animal Health Incorporated Common Stock	C	B	C	2.2x	11.9%	55.4%	29.9%	$22.14
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.0x	-0.9%	61.4%	16.5%	$12.25
AXSMAxsome Therapeutics, Inc	D	B	C	12.1x	56.9%	93.2%	—	$179.25
CYTKCytokinetics Inc.	F	D	C	134.8x	-21.1%	—	—	$65.60
PTGXProtagonist Therapeutics, Inc	F	B	A	32.1x	34.8%	—	—	$140.06
ARWRArrowhead Research Corporation	D	A	B	13.5x	16.9%	—	—	$64.19
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
TGTXTG Therapeutics, Inc.	D	B	B	10.4x	76.1%	82.4%	—	$54.29
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	964.6x	—	—	—	$295.51
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$92.88
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	6680.4x	—	—	—	$93.19
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	D	8.3x	-7.5%	98.2%	—	$43.54
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.1x	9.3%	39.3%	-18.4%	$20.30
ALKSAlkermes Inc. plc	D	C	B	4.2x	10.8%	84.6%	—	$41.75
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$159.56
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	26.6x	53.5%	70.9%	—	$92.83
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.8x	54.9%	95.4%	—	$302.96
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	A	A	7.0x	58.9%	89.8%	—	$75.79

About Eocene Ltd. Ordinary Shares

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.